Phase III randomized trial of stereotactic ablative radiotherapy (SAbR) for oligometastatic advanced renal carcinoma (EA8211-SOAR).

被引：1
|
作者：
Kim, Se Eun
Cole, Suzanne
Wulff-Burchfield, Elizabeth Marie
Wentland, Andrew
Hannan, Mu-Han
Kapur, Payal
Shevrin, Daniel
Gurley, Tami
Lin, John Kent
Brugarolas, James
Timmerman, Robert D.
Mckay, Rana R.
Wagner, Lynne I.
Haas, Naomi B.
Carducci, Michael Anthony
机构：
[1] Univ Texas Southwestern Med Ctr, Dallas, TX USA
[2] DFCI PCC Fellowship Program Attendings, Boston, MA USA
[3] Univ Kansas, Med Ctr, Westwood, KS USA
[4] Univ Wisconsin, Madison, WI USA
[5] Univ Texas Southwestern, Dept Pathol, Dallas, TX USA
[6] Northshore Univ Hlth Syst, Evanston, IL USA
[7] UT Southwestern Med Ctr, Dallas, TX USA
[8] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[9] Univ Texas Southwestern, Div Hematol & Oncol, Dept Internal Med, Dallas, TX USA
[10] Univ Texas Southwestern Med Ctr, Radiat Oncol, Dallas, TX USA
[11] Univ Calif San Diego, La Jolla, CA USA
[12] Wake Forest Univ, Sch Med, Winston Salem, NC USA
[13] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
261-566-11347; 261-137-3222-3876-5567; 283-424-3231; 261-492-3532-2370-7650-2700; 3282-270-434-2806; 261-492-199; 261-137; 11; 10; 6; 5; 4;
D O I：
10.1200/JCO.2024.42.4_suppl.TPS489
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：TPS489 / TPS489
页数：1
相关论文
共 50 条
  • [1] Phase III randomized trial of stereotactic ablative radiotherapy (SAbR) for oligometastatic advanced renal carcinoma (EA8211-SOAR).
    Cole, Suzanne
    Kim, Se Eun
    Wentland, Andrew
    Lin, Mu-Han
    Kapur, Payal
    Wulff-Burchfield, Elizabeth Marie
    Shevrin, Daniel
    Gurley, Tami
    Lin, John C.
    Wagner, Lynne I.
    McKay, Rana R.
    Brugarolas, James
    Qin, Qian
    Gunter, Tyler
    Kyriakopoulos, Christos
    Harichand-Herdt, Seema
    Sykes, Glenn
    Haas, Naomi Balzer
    Carducci, Michael A.
    Hannan, Raquibul
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL) : TPS615 - TPS615
  • [2] Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
    David A. Palma
    Robert Olson
    Stephen Harrow
    Rohann J. M. Correa
    Famke Schneiders
    Cornelis J. A. Haasbeek
    George B. Rodrigues
    Michael Lock
    Brian P. Yaremko
    Glenn S. Bauman
    Belal Ahmad
    Devin Schellenberg
    Mitchell Liu
    Stewart Gaede
    Joanna Laba
    Liam Mulroy
    Sashendra Senthi
    Alexander V. Louie
    Anand Swaminath
    Anthony Chalmers
    Andrew Warner
    Ben J. Slotman
    Tanja D. de Gruijl
    Alison Allan
    Suresh Senan
    BMC Cancer, 19
  • [3] Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial
    Robert Olson
    Lindsay Mathews
    Mitchell Liu
    Devin Schellenberg
    Benjamin Mou
    Tanya Berrang
    Stephen Harrow
    Rohann J. M. Correa
    Vasudeva Bhat
    Howard Pai
    Islam Mohamed
    Stacy Miller
    Famke Schneiders
    Joanna Laba
    Derek Wilke
    Sashendra Senthi
    Alexander V. Louie
    Anand Swaminath
    Anthony Chalmers
    Stewart Gaede
    Andrew Warner
    Tanja D. de Gruijl
    Alison Allan
    David A. Palma
    BMC Cancer, 20
  • [4] Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial
    Palma, David A.
    Haasbeek, Cornelis J. A.
    Rodrigues, George B.
    Dahele, Max
    Lock, Michael
    Yaremko, Brian
    Olson, Robert
    Liu, Mitchell
    Panarotto, Jason
    Griffioen, Gwendolyn H. M. J.
    Gaede, Stewart
    Slotman, Ben
    Senan, Suresh
    BMC CANCER, 2012, 12
  • [5] Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial
    David A Palma
    Cornelis J A Haasbeek
    George B Rodrigues
    Max Dahele
    Michael Lock
    Brian Yaremko
    Robert Olson
    Mitchell Liu
    Jason Panarotto
    GwendolynHMJ Griffioen
    Stewart Gaede
    Ben Slotman
    Suresh Senan
    BMC Cancer, 12
  • [6] Stereotactic ablative radiotherapy for oligometastatic cancers: Efficacy and toxicity results from the randomized SABR-COMET Trial
    Senan, S.
    Olson, R.
    Harrow, S.
    Gaede, S.
    Louie, A.
    Haasbeek, C.
    Mulroy, L.
    Lock, M.
    Rodrigues, G.
    Yaremko, B.
    Schellenberg, D.
    Ahmad, B.
    Griffioen, G.
    Senthi, S.
    Liu, M.
    Moore, K.
    Currie, S.
    Bauman, G.
    Warner, A.
    Palma, D.
    ANNALS OF ONCOLOGY, 2018, 29
  • [7] Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial
    Olson, Robert
    Mathews, Lindsay
    Liu, Mitchell
    Schellenberg, Devin
    Mou, Benjamin
    Berrang, Tanya
    Harrow, Stephen
    Correa, Rohann J. M.
    Bhat, Vasudeva
    Pai, Howard
    Mohamed, Islam
    Miller, Stacy
    Schneiders, Famke
    Laba, Joanna
    Wilke, Derek
    Senthi, Sashendra
    Louie, Alexander, V
    Swaminath, Anand
    Chalmers, Anthony
    Gaede, Stewart
    Warner, Andrew
    de Gruijl, Tanja D.
    Allan, Alison
    Palma, David A.
    BMC CANCER, 2020, 20 (01)
  • [8] Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
    Palma, David A.
    Olson, Robert
    Harrow, Stephen
    Correa, Rohann J. M.
    Schneiders, Famke
    Haasbeek, Cornelis J. A.
    Rodrigues, George B.
    Lock, Michael
    Yaremko, Brian P.
    Bauman, Glenn S.
    Ahmad, Belal
    Schellenberg, Devin
    Liu, Mitchell
    Gaede, Stewart
    Laba, Joanna
    Mulroy, Liam
    Senthi, Sashendra
    Louie, Alexander V.
    Swaminath, Anand
    Chalmers, Anthony
    Warner, Andrew
    Slotman, Ben J.
    de Gruijl, Tanja D.
    Allan, Alison
    Senan, Suresh
    BMC CANCER, 2019, 19 (01)
  • [9] Phase II trial of stereotactic ablative radiation (SAbR) for oligometastatic kidney cancer.
    Hannan, Raquibul
    Christensen, Michael
    Robles, Liliana
    Christie, Alana
    Garant, Aurelie
    Desai, Neil Bipinchandra
    Hammers, Hans J.
    Arafat, Waddah
    Bowman, Isaac Alexander
    Cole, Suzanne
    Courtney, Kevin Dale
    Woldu, Solomon L.
    Bagrodia, Aditya
    Margulis, Vitaly
    Cadeddu, Jeffrey A.
    Choy, Hak
    Sher, David
    Brugarolas, James
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [10] Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
    Palma, David A.
    Olson, Robert
    Harrow, Stephen
    Gaede, Stewart
    Louie, Alexander V.
    Haasbeek, Cornelis
    Mulroy, Liam
    Lock, Michael
    Rodrigues, George B.
    Yaremko, Brian P.
    Schellenberg, Devin
    Ahmad, Belal
    Senthi, Sashendra
    Swaminath, Anand
    Kopek, Neil
    Liu, Mitchell
    Moore, Karen
    Currie, Suzanne
    Schlijper, Roel
    Bauman, Glenn S.
    Laba, Joanna
    Qu, X. Melody
    Warner, Andrew
    Senan, Suresh
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (25) : 2830 - +
12345